Evidence map›Paper›PMID 24938760›Full record

ArticleDiagnostic microbiology and infectious disease2014

Rapid urine antigen testing for Streptococcus pneumoniae in adults with community-acquired pneumonia: clinical use and barriers.

Aaron M Harris, Susan E Beekmann, Philip M Polgreen, Matthew R Moore

Open access · hybridAbstract read
In one paragraph

Article in Diagnostic microbiology and infectious disease, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. A Reappraisal of Streptococcal Urinary Antigen Testing for Antibiotic Stewardship.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  5. Pneumococcal Urinary Antigen Testing in United States Hospitals: A Missed Opportunity for Antimicrobial Stewardship.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  6. Frontiers in immunology · 2018
    Review
  7. Review
  8. Article
  9. Severe community-acquired pneumonia and positive urinary antigen test for S. pneumoniae: amoxicillin is associated with a favourable outcome.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aaron M HarrisRespiratory Disease Branch, Centers for Disease Control and Prevention, Atlanta, Georgia; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: ieo9@cdc.gov.
Susan E BeekmannUniversity of Iowa Carver College of Medicine, Iowa City, Iowa.
Philip M PolgreenUniversity of Iowa Carver College of Medicine, Iowa City, Iowa.
Matthew R MooreEpidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia.
Epidemic Intelligence Service · USUniversity of Iowa · US

Funding

Intramural CDC HHS CC999999NCEZID CDC HHS 5U50CK000187NCEZID CDC HHS U50 CK000187
6 · The paper itself

Abstract

Streptococcus pneumoniae (pneumococcus) is the most common bacterial etiology of community-acquired pneumonia (CAP) in adults, a leading cause of death. The majority of pneumococcal CAP is diagnosed by blood culture, which likely underestimates the burden of disease. The 2007 CAP guidelines recommend routine use of the rapid pneumococcal urinary antigen (UAg) test. To assess the how pneumococcal UAg testing is being used among hospitalized adult CAP patients and what barriers restrict its use, a Web-based survey was distributed in 2013 to 1287 infectious disease physician members of the Emerging Infectious disease Network of the Infectious Disease Society of America. Of 493 eligible responses, 65% use the pneumococcal UAg test. The primary barrier to UAg use was availability (46%). UAg users reported ordering fewer other diagnostic tests and tailoring antibiotic therapy. Increased access to UAg tests could improve pneumonia management and pneumococcal CAP surveillance.

Indexed as

Antigens, BacterialCommunity-Acquired InfectionsDisease ManagementHealth Care SurveysHumansImmunologic TestsPneumonia, PneumococcalPractice Patterns, Physicians'Streptococcus pneumoniaeUnited StatesUrinalysisAntigens, BacterialCommunity acquired pneumoniaPneumococcusRapid diagnosticsUrine antigen test

Identifiers

PMID24938760
PMCPMC5800492
OpenAlexW2066385205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.